Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease

doi:10.3748/wjg.v13.i26.3540

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 26

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4586)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

429

HTML

3604

Figures (1-2)

360

Tables (1-3)

193

Sum=4586

Jul 14, 2007 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (201)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Jul 14, 2007; 13(26): 3540-3553
Published online Jul 14, 2007. doi: 10.3748/wjg.v13.i26.3540

Full Size Figure Download Figure

Figure 1 Lipid metabolism in liver. All steps indicated by + are stimulated by insulin. Insulin suppresses the secretion of VLDL and the β-oxidation of fatty acids. Thus hyperinsulinemia in the setting of insulin resistance favors TAG accumulation in liver. TAG: triglycerides; VLDL: very low density lipoprotein; FA: fatty acid; NEFA: nonesterified fatty acids; DNL: de novo lipogenesis; ATP: adenosine triphosphate.

Citation: Qureshi K, Abrams GA. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 2007; 13(26): 3540-3553
URL: https://www.wjgnet.com/1007-9327/full/v13/i26/3540.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i26.3540